|
|
A British company may have turned the tables on the hospital superbug MRSA by stripping away its protective armour, it has been reported.
According to official statistics, MRSA and other hospital acquired infections kill at least 5,000 people every year. But the true figure could be far higher.
The new breakthrough, reported in New Scientist magazine, follows work done in the 1990s which showed that compounds containing the amino acid glycine greatly increased MRSA's susceptibility to methicillin.
A team led by Michael Levey, at the drug company Pharmaceutica in Worcestershire, found that the dose needed to kill MRSA could be reduced from 256 milligrams per litre to just 4 mg/l.
|
|
